China's Covid vaccines very weak, India need not worry, says Assam CM

Amid a spike in Covid cases in China and other countries, the Assam CM said people should not fear Covid anymore in India

Himanta Biswa Sarma
IANS Guwahati
1 min read Last Updated : Dec 21 2022 | 11:29 PM IST

Amid a sudden spike in Covid cases in China and a few other countries, Assam Chief Minister Himanta Biswa Sarma asserted that in India, people should not fear Covid anymore.

"The COVID vaccines given in China were very weak. India has administered good quality vaccines. So, we need not be worried," he said on the sidelines of a programme here.

Sarma also said that Covid vaccines prepared by other countries besides China were also strong in nature.

He said that in Assam, no positive Covid cases were detected on Wednesday.

"If anything is required, it will be done by the Central government," he said.

According to National Health Mission data, a total of 112 Covid tests were conducted in Assam on Wednesday.

The Central government has issued an advisory on Wednesday in the wake of a sudden rise in Covid cases in China and a few other countries. The people were advised to wear masks and get vaccinated.

Meanwhile, Union Health Minister Mansukh Mandaviya chaired a meeting with experts and senior officials to review the situation in the country.

--IANS

tdr/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Himanta Biswa SarmaCoronavirus Vaccine

First Published: Dec 21 2022 | 11:29 PM IST

Next Story